While current symptomatic treatments for AD primarily target the cholinergic hypothesis—which links cognitive decline to acetylcholine deficiency and loss of cholinergic neurons [12]—emerging evidence highlights the multifaceted role of AChE in neurodegeneration. This evidence concerns the gene ACHE and Alzheimer disease.